Helmink BA, Reddy SM, Gao J, Zhang S, Basar R, Thakur R, Yizhak K, Sade-Feldman M, Blando J, Han G, Gopalakrishnan V, Xi Y, Zhao H, Amaria RN, Tawbi HA, Cogdill AP, Liu W, LeBleu VS, Kugeratski FG, Patel S, Davies MA, Hwu P, Lee JE, Gershenwald JE, Lucci A, Arora R, Woodman S, Keung EZ, Gaudreau PO, Reuben A, Spencer CN, Burton EM, Haydu LE, Lazar AJ, Zapassodi R, Hudgens CW, Ledesma DA, Ong S, Bailey M, Warren S, Rao D, Krijgsman O, Rozeman EA, Peeper D, Blank CU, Schumacher TN, Butterfield LH, Zelazowska MA, McBride KM, Kalluri R, Allison J, Petitprez F, Fridman WH, Sauts-Fridman C, Hacohen N, Rezvani K, Sharma P, Tetzlaff MT, Wang L , Wargo JA
FGF21 as a mediator of adaptive responses to stress and metabolic benefits of anti-diabetic drugs
doi: 10.1016/j.autrev.2018.01.009 31 BrittainEMuirheadNFinlayAYVyasJ
Jill Lezaic, a Board Certified Family Physician with over two decades of experience